Results 111 to 120 of about 19,558 (200)

Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome [PDF]

open access: yes, 2018
The current mainstay of the treatment and secondary thromboprophylaxis of thrombotic antiphospholipid syndrome (APS) is anticoagulation with warfarin or other vitamin K antagonists (VKAs).
Cohen, H   +3 more
core  

Mass-conserving self-similar solutions to coagulation-fragmentation equations [PDF]

open access: yesarXiv, 2019
Existence of mass-conserving self-similar solutions with a sufficiently small total mass is proved for a specific class of homogeneous coagulation and fragmentation coefficients. The proof combines a dynamical approach to construct such solutions for a regularised coagulation-fragmentation equation in scaling variables and a compactness method.
arxiv  

Weak solutions to the continuous coagulation equation with multiple fragmentation [PDF]

open access: yesarXiv, 2011
The existence of weak solutions to the continuous coagulation equation with multiple fragmentation is shown for a class of unbounded coagulation and fragmentation kernels, the fragmentation kernel having possibly a singularity at the origin. This result extends previous ones where either boundedness of the coagulation kernel or no singularity at the ...
arxiv  

Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Life-long vitamin K antagonist (VKA) therapy is recommended as a standard of care in antiphospholipid syndrome (APS) patients with thrombosis.
Rachel Gehlen   +7 more
doaj  

Lupus Anticoagulunt Associated with Transient Severe Factor X Deficiency: A Report of Two Patients Presenting with Major Bleeding Complications [PDF]

open access: yes, 2003
Acquired factor X (FX) deficiency is rare, but has been reported in diverse disease states, including systemic amyloidosis and respiratory infections. FX deficiency associated with lupus anticoagulant (LA) and a bleeding diathesis has not been previously
Al-Khatib, Hani, MD   +3 more
core   +1 more source

Atherogenesis and atherosclerosis in primary antiphospholipid syndrome [PDF]

open access: yes, 2013
: In the late seventies the term “Haematological Stress Syndrome” defined some haematological abnormalities appearing in the course of acute and chronic disorders, such as raised plasma levels of fibrinogen (FNG) and factor VIII, reduced fibrinolytic ...
Ames, Paul Richard Julian
core  

Acquired hemophilia A in a patient with advanced prostate cancer [PDF]

open access: yes, 2015
Acquired hemophilia A (AHA) is a rare disorder that results from the presence of autoantibodies against the clotting factor VIII (FVIII) causing hemorrhagic disorders.
Bastos, Diogo Assed   +6 more
core   +1 more source

Discrete Coagulation-Fragmentation equations with multiplicative coagulation kernel and constant fragmentation kernel [PDF]

open access: yesarXiv
Here, we study a discrete Coagulation-Fragmentation equation with a multiplicative coagulation kernel and a constant fragmentation kernel, which is critical. We apply the discrete Bernstein transform to the original Coagulation-Fragmentation equation to get two new singular Hamilton-Jacobi equations and use viscosity solution methods to analyze them ...
arxiv  

NEWLY DIAGNOSED HEREDITARY FACTOR V DEFICIENCY IN A PATIENT PRESENTING WITH DEEP VEIN THROMBOSIS: A Rare Case

open access: yesHematology, Transfusion and Cell Therapy
Objective: Factor V (FV) is a crucial regulator of hemostasis, functioning as both a procoagulant and an anticoagulant glycoprotein within the coagulation cascade. In plasma, FV exists as an inactive precursor, which is activated by thrombin or factor Xa
Songül Beskisiz Dönen   +3 more
doaj  

ACQUIRED HEMOPHILIA A IN A 3-YEAR-OLD PEDIATRIC PATIENT: A CASE REPORT OF RARE AND POTENTIALLY FATAL BLEEDING DISORDER

open access: yesHematology, Transfusion and Cell Therapy
Introduction: Acquired hemophilia A (AHA) is a rare severe autoimmune bleeding disorder with significant morbidity and mortality mainly occurring in older adults (average age 75). The condition is extremely rare in children.
Z Alrajhi, LLE Souza, M Carcao
doaj  

Home - About - Disclaimer - Privacy